Abstract
Here we describe the non-canonical control of gene expression in Leishmania, a single-cell parasite that is responsible for one of the major neglected tropical diseases. We discuss the lack of regulated RNA synthesis, the post-transcriptional gene regulation including RNA stability and regulated translation. We also show that genetic adaptations such as mosaic aneuploidy, gene copy number variations and DNA sequence polymorphisms are important means for overcoming drug challenge and environmental diversity. These mechanisms are discussed in the context of the unique flow of genetic information found in Leishmania and related protists.
Keywords: Leishmania, Aneuploidy, Translational regulation, Gene copy number
1. Introduction
Infections by parasites of the genus Leishmania manifest in three main forms: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL) and visceral leishmaniasis (VL), which together are counted among the most important neglected tropical diseases [1]. Leishmaniasis is endemic in large parts of the tropical and subtropical regions of the World and poverty-related [2]. The genus Leishmania is part of the order Trypanosomatida and of the early-branching phylum Euglenozoa [3], [4]. Leishmania spp. are closely related to other important pathogens, such as the causative agents of human sleeping sickness, Trypanosoma brucei ssp, and T. cruzi, the aetiologic agent of Chagas disease.
There are over 20 human-pathogenic species of Leishmania, divided into sub-genera, of which Leishmania and Viannia [5], [6] are the most prominent. All leishmaniae undergo a biphasic life cycle with two main morphologically distinct stages. In their vectors, sandflies such as Phlebotomus spp. and Lutzomyia spp., leishmaniae proliferate rapidly as elongated, flagellated promastigotes within the midgut of females, which require mammalian blood for fertility. These promastigotes undergo small morphological changes during the insect stage, emerging as infective, highly motile forms that upon injection into the mammalian skin during the next sandfly blood meal end up in phagocytic, antigen-presenting cells (APCs). Within those, they undergo a critical differentiation into ovoid, aflagellated, non-motile amastigotes that reside and proliferate inside the phagosomes of macrophages and other APCs. By shedding protein-loaded exosomes [7], they can modulate macrophage activity and thus ensure their survival.
Proliferating amastigotes will destroy the host cell, escape and infect new APCs. The ensuing immune reaction involves influx of various immune cells, inflammatory responses, tissue swelling and destruction, either restricted to the infection site (CL), spreading through the lymphatic system (diffuse CL, MCL), or afflicting the major lymphatic organs (spleen, liver, bone marrow) in VL. The latter is almost invariably lethal in untreated cases or when therapeutic options fail. The manifestation of Leishmania infections in CL, MCL or VL is mostly preordained by the infecting species, but the host immune status has also a considerable influence on the outcome. In recent years, it has become increasingly clear that not all Leishmania infections cause a symptomatic disease and that parasites can persist in humans in subclinical infections for years [8]. These subclinical cases are thought to constitute an important reservoir for anthroponotic Leishmania species but may exacerbate upon permanent or temporary immune suppression.
Conversion from the insect stage to the mammalian stage requires Leishmania to change its gene expression. While gene expression in most eukaryotes is controlled mainly at the level of transcription initiation, by cis-acting promoters and trans-acting transcription factors [9], Leishmania spp. and the entire order Trypanosomatida lack gene-specific, regulated transcription by RNA Polymerase II, missing both canonical promoter elements and genes for cognate transcription factors [10]. Rather, Leishmania chromosomes comprise of large polycistronic transcription units (PTUs) of functionally unrelated genes [11], [12]. The regions between the PTUs are called strand switch regions where transcription is initiated and terminated [13], [14] (Fig. 1). However, episomal DNA, e.g. plasmid- or cosmid-based transgenes, are efficiently transcribed [15], [16], without harbouring strand switch region DNA. This argues for additional, unspecific initiation of RNA synthesis. The polycistronic pre-mRNAs are processed into mature mRNAs by coupled trans-splicing of a leader RNA and polyadenylation [17]. With very few exceptions, Leishmania genes lack introns and cis-splicing [18], eliminating alternative splicing as a means of gene regulation.
Fig. 1.
Polycistronic transcription and RNA processing in Leishmania. The figure shows the distribution of coding sequences (CDSs) on the L. donovani chromosome 2. Arrows in red signify upper strand CDSs, green arrows indicate lower strand CDSs. Polycistronic transcripts are generated and processed into mature, monocistronic mRNA by trans-splicing of a 39-nucleotide spliced leader RNA (SL) and coupled poly-adenylation (poly A). The SL also contributes the CAP structure (yellow diamond) to the mRNA. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
The differentiation from the non-pathogenic promastigote form of the insect host to the pathogenic amastigote stage is induced by factors that are not yet fully understood. It is known, however, that for a range of Leishmania spp., an acidic pH of 5.5 and a temperature increase to 33–37 °C are the major triggers for differentiation even under axenic culture conditions [19], [20]. Conversion into amastigotes is crucial for survival within the mammalian host and thus plays an important role in the pathogenicity of Leishmania spp.. The pivotal role of heat shock proteins in differentiation and adaption was proposed early and has been extensively studied in Leishmania [21].
In the following, we shall discuss the ways by which Leishmania can respond to environmental stimuli using post-transcriptional gene regulation and adapt to environmental challenges by constitutive genetic diversity and selection.
2. Post-transcriptional responses to environmental signals
2.1. Post transcriptional regulation
The response to environmental stimuli is mediated by post-transcriptional regulation of gene expression in Leishmania spp., a fact that was demonstrated by nuclear run-on experiments and using the universal cellular heat shock response as model [22], [23]. Nuclear run-on and microarray studies showed that Leishmania genes are constitutively transcribed, consistent with the lack of gene-specific transcription regulation. However, a global down regulation of RNA synthesis was observed for axenic amastigotes when compared with promastigotes [24], [25]. The stage differentiation process itself is associated with a globally increased protein synthesis [26], but also with specific increases for amastigote stage-specific proteins [27].
2.2. The role of mRNA stability and translation efficiency
While early research focused mainly on mRNA levels of selected genes, later proteome analysis and system-wide RNA abundance studies revealed that the regulation of Leishmania gene expression occurs on levels other than RNA synthesis, i.e. RNA processing and stability [28]. Even then, changes of mRNA abundance do not necessarily translate into corresponding protein synthesis rates or abundance, hinting at translation efficiency and protein half life as additional targets of regulation [29], [30], [26], [31], [32], [33].
RNA half life as a post-transcriptional regulatory mechanism was shown for resistance to antimony, which differs in various Leishmania species and correlates with the stability of the mRNA coding for aquaglyceroporin (AQP1) and is mediated by the 3′-untranslated region (3′ UTR) [34]. RNA stability is regulated by non-long terminal repeat retrotransposons in the 3′ UTR. In L. major, two families of these Short Interspersed DEgenerated Retroposons (SIDER) could be identified, LmSIDER1 and LmSIDER2. For SIDER2 it was demonstrated that it destabilises the mRNA and even leads to an mRNA decay [35], [36], while the SIDER1 family can regulate mRNA translation in a stage-specific manner [37].
2.3. Ribosome profiling shows a regulated translation in Leishmania
RNA-Seq analysis is a powerful tool to obtain a genome-wide view of mRNA abundance patterns and is often seen as the equivalent to genome-wide gene expression analysis. However, in Leishmania and the related Trypanosoma spp., inducible mRNA abundance and corresponding protein synthesis/abundance show only a limited correlation [26], [33], [38], [39], [40]. To study the effect of environmental triggers on gene expression in the parasite, the steady-state level of proteins or translation rates can be measured. The former can be done by mass spectrometry-based proteomics [26], [27], [41] and the latter is achieved by ribosome profiling analysis [42] or a combined metabolic labeling/mass-spectrometry strategy [43]. The combination of ribosome profiling and RNA-Seq facilitates not only correlation studies of mRNA abundance and translation, but also gives a measure of the relative translation efficiencies of mRNAs in response to environmental triggers. Ribosome profiling analyses in L. donovani, combined with RNA-Seq, showed that inhibition of HSP90, while having no global impact on gene expression, changes steady state levels for many mRNAs and causes increased or decreased protein synthesis rates for <10% of the proteome. RNA abundance variations correlate poorly with changes to translation rates [33]. Among the proteins that show increased synthesis upon HSP90 inhibition are many that are known as markers of early amastigote differentiation, while induced morphological changes are reminiscent of in vitro stage conversion [16], [26], [33], [44].
2.4. Translation factors
While no canonical transcription factors are involved in controlling gene expression in Leishmania, translation factors may play important roles. Axenically induced amastigote differentiation coincided with reduced overall translation and phosphorylation of translation factor eIF2α [45]. Reduction of protein synthesis in amastigotes may reflect the adaptation to the reduced proliferation rate observed for the intracellular stage [46]. Furthermore, it is known for eukaryotes that stress causes a switch from cap-dependent to cap-independent translation. Leishmania spp. can adapt their translation machinery to environmental stress by a special cap structure (cap-4) and associated cap-binding protein eIF4E [47]. There are several factors, e.g. Leish4E-IP, that bind to eIF4E and thus mediate the switch from cap-dependent to alternative translation initiation mechanisms [48]. Apart from these findings, very little is known about translation factors and their role in the regulation of inducible gene expression in Leishmania.
2.5. Post-translational modifications
Post-translational modifications (PTMs) are also involved in the regulation of gene expression patterns by influencing the function and stability of proteins through phosphorylation, acetylation, methylation, and glycosylation. High throughput liquid chromatography/tandem mass spectrometry (LC-MS/MS) methodologies were used to study the prevalence of PTMs during axenic differentiation into amastigotes and showed altered abundance of modified proteins [49], [50], [51]. MAP kinases (MAPK), for instance, play a major role in altering gene expression profiles. They are highly conserved serine/threonine-specific protein kinases in all eukaryotes and are important in signal transduction cascades. By phosphorylating their substrates, MAPKs regulate critical cellular functions in Leishmania affecting cell viability, parasitic life cycle control, morphology and drug resistance [52], [53], [54], [55], [56], [57], [58], [59]. Phosphorylation of HSP70 and HSP90 by the L. donovani MAP kinase 1 is thought to affect the stability of heat shock proteins and their functions during the life cycle [60].
Casein kinases also play crucial roles in overcoming environmental adversity. They are exported to the host cell cytoplasm via exosomes and interact with parasite chaperones and host proteins [61], [62], [63], [64], [94].
3. Genetic diversity and selection under environmental challenge
The lack of gene regulation at the transcription level and the absence of cis-splicing in Leishmania, the Trypanosomatida and possibly all Euglenozoa sets these organisms apart from other eukaryotic phyla [10], [28], [65], [66]. Although Leishmania chromosomes are divided into gene arrays that are transcribed in a polycistronic mode [11], [13], [67], those arrays do not constitute operons of jointly regulated, functionally related genes. Nevertheless, Leishmania populations are able to adapt to environmental adversity.
Starting in the 1980s, researchers discovered that certain Leishmania genes were present in more than one copy per haploid set of chromosomes [68], [69], [70], [71], [72], and the copy numbers often varied between species and parasite isolates. This already hinted at gene copy number variation (CNV) as a mechanism of genetic adaption.
The advent of reverse genetics in Leishmania research [73], [74] provided more puzzles. Double-allelic gene replacement by homologous recombination using different selection marker genes for both alleles often left detectable copies of the genes of interest (GOI), in spite of a successful and verified gene replacement and marker gene insertion [74], [75].
The availability of deep sequencing technology in recent years has greatly expanded our knowledge of the structure and dynamics of Leishmania genomes. Parasite populations selected under virtually any sort of pressure, e.g. drug challenge, temperature stress, pH milieu, oxidative stress, but also loss-of-function mutations with growth defects, can be subjected to whole genome sequencing (WGS) alongside the pre-selection parental strain. The resulting sequence read densities can then be analysed for ploidy changes, gene CNVs, and single nucleotide polymorphisms (SNPs) [76].
3.1. Aneuploidy and mosaic aneuploidy
Individual chromosome ploidy in Leishmania is highly variable within populations [77], [78], [79]. Between one and up to six sister chromosomes may occur. Chromosome ploidy can be assessed from the relative NGS read alignment density, normalised to a reference strain [76] (Fig. 2A). Intermediate fold values can indicate mosaic aneuploidy, e.g. variances within the population, or partial chromosome duplication events. Distinction between these possibilities is done by plotting read alignment density against the length of the chromosome: even read alignment density indicates whole chromosome/partial population changes (Fig. 2B), while localised read alignment density increases may hint at partial chromosome/whole population events.
Fig. 2.
Constitutive and selected aneuploidy in Leishmania donovani selected under IC50 of a pteridin reductase 1 inhibitor (PTR1-i) or an equivalent dose of solvent (DMSO) for 40 days. (A) NGS read alignment densities were established for each chromosome using the Bowtie2 algorithm, normalised against the overall average read density set at 2, and displayed as heat map. Note that i) chromosome 31 is constitutively tetrasomic, ii)chromosomes 8, 12, and 24 are constitutively trisomic, and chromosome 23 shows trisomy after PTR1-i selection. In addition, chromosome 5 shows an intermediate ploidy indicating mosaic aneuploidy or partial chromosome amplification. (B) Sequence read alignment over chromosome 5 for DMSO- (upper panel) or PTR1-i-selected (lower panel) shows equal relative read distribution, indicating mosaic aneuploidy for chromosome 5 in the PTR1-i-selected population.
Aneuploidy has been studied extensively in the context of drug resistance. Decades of use of pentavalent antimony-based drugs in endemic regions have led to wide-spread resistance, rendering these drugs almost obsolete in certain areas [80], [81], [82], [83]. The advances of systems biology strategies in Leishmania spp. confirmed initial proposals [84] linking antimony resistance with aneuploidy patterns specific for resistant parasites [85], [86], [87]. However, mosaic aneuploidy also plays a role in the adaption to vector and host as distinct patterns of ploidy are observed for vector- and host-derived leishmaniae [86], but also for in vitro cultivated cells [86], [88], [89].
Even more telling is a recent finding comparing somy patterns of identical L. donovani strains obtained from cultivated parasites or directly from clinical biopsies. This approach skips the in vitro cultivation of parasites and the concomitant karyotypic diversification prior to whole genome sequencing. While cultured parasites showed a wide variety of somy patterns, ploidies were remarkably similar for bone-marrow-derived parasite genomes [90], in keeping with comparable selective pressures within the human hosts.
In multicellular organisms, aneuploidy is known to have severe consequences, including tumour formation and chromosome instability [91], [92], [93]. Yet, the leishmaniae seem to cope well with genome plasticity. Firstly, aneuploidy is reversed quickly once the benefits of a supernumerary chromosome expire. Secondly, over expression due to additional gene copies appears to be limited at the protein level [86], [94]. Regulated translation may therefore play a role in ameliorating the effects of aneuploidy.
3.2. Gene CNVs
As mentioned before, gene CNVs were observed for Leishmania species and strains, often affecting heat shock gene arrays [12], [44], [68], [69], [70], [71], [72], which can be assumed to mediate tolerance against various physical and chemical stresses. Indeed, increased abundances of HSP90 or HSP70 appear to protect Leishmania spp. against antimony-containing drugs [95], [96], [97]. Drug selection pressure can also lead to increased copy numbers for genes encoding ABC transporter proteins [98]. The prevalent mechanism for gene amplification was shown to depend on the SIDERs that are distributed over the Leishmania genomes. In addition to their roles in mRNA stability, they can be found flanking amplified intra-chromosomal and episomal genes and gene clusters, suggesting a role of such repeats in the formation of linear and circular episomes [94], [99]. Such amplifications occur frequently and stochastically within a given population and, like mosaic aneuploidy, contribute to the constitutive genetic diversity within Leishmania isolates [85], [86], [87]. In fact, these fluctuations of gene copy numbers are known to account for a majority of genetic adaptations [100]. However, while gene dosage affects the abundance of the corresponding RNA(s) proportionally, their effect on protein abundance during natural gene copy number variation [86] and targeted over expression [94], [101] is extenuated, likely due to modulated translation. Still, increased gene copy numbers lead to increased expression.
4. SNPs
SNPs in non-coding or protein-coding sequences may affect expression or function, respectively, of genes and their products. They are usually associated with a loss-of-function phenotype. In the context of drug resistance, SNPs were found in Leishmania selected for resistance to the antileishmanial drug miltefosine. Selected parasites carry a plethora of SNPs in the miltefosine transporter gene causing amino acid exchanges or open reading frame shifts [102], [103].
Another example for the selection of SNPs involves the L. major P46 virulence enhancing protein, which, depending on the geographic origin of L. major isolates, shows distinct patterns of SNPs. Defined SNP patterns were indeed selected in vitro and in murine hosts, suggesting a role of P46 sequence polymorphism in the adaption to diverse reservoir hosts found in various L. major-endemic regions [104].
4.1. Mimicking CNV in the laboratory
Adaptive, extrachromosomal gene amplifications can be mimicked in a laboratory setting by complementation genetics, more specifically by functional cloning from a cosmid library representing a Leishmania genome [15], [105], [106], [107], [108], [109]. Since Leishmania genes do not contain introns but need their flanking sequences for proper RNA processing via trans-splicing and polyadenylation [110], unaltered, genomic DNA-bearing cosmids contain all the information needed for proportional over expression of several neighbouring gene loci. The compactness of the Leishmania genomes (~32–34 Mb) contributes to this, with less than 5000 individual cosmid clones covering >99% of the genome [107], and allowing for a genome-wide search for dominant genetic markers using a manageable number of individual transfectants. Using shuttle cosmid vectors, propagation in Escherichia coli and Leishmania spp. is feasible. Lately, the technology was greatly improved by the use of next generation sequencing (NGS) to map the origin of selected cosmids and to establish the relative preference within a number of selected gene loci [111], [112], [113]. This cos-seq strategy can now be employed to identify dominant drug resistance markers for established drugs and for drug leads, improving sustainable drug development [111], [114].
5. Conclusions
By dispensing with individually regulated RNA polymerase II transcription, Leishmania spp., like all Trypanosomatida, lost an important route to up-regulate the expression of genes needed for overcoming environmental adversity, while allowing them to dispense with cis- and trans-acting transcription regulators, thus reducing genome size. The constitutive transcription of most of their genome and the resulting waste of biochemical energy equivalents is compensated in part by the compact arrangement of coding sequences, the lack of cis-splicing and introns, and the parasitic life style, utilising the host's energy resources. Generally speaking, obligate parasites such as Leishmania spp. live in the stable environments of either sandflies or mammals and are thus shielded against acute environmental changes. Nevertheless, their extreme and constitutive genetic variability as expressed in mosaic aneuploidy, episomal and intrachromosomal gene amplification, a short generation time, and an effective post-transcriptional stress response allows them to adapt — as a population — to environmental challenges in an exemplary fashion.
6. Authors statement
J.G. and J.C. contributed equally to the creation of this manuscript, including conceptualisation, literature research, drafting and finalising of the manuscript. J.C. contributed the Figures.
Acknowledgements
We wish to thank H. Fehling and C. Kröber-Boncardo for a critical reading of the manuscript. Both authors are staff employees of the BNITM.
References
- 1.WHO. Integrating neglected tropical diseases into global health and development: fourth WHO report on neglected tropical diseases. 2017.
- 2.Alvar J., Velez I.D., Bern C., Herrero M., Desjeux P., Cano J. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE. 2012;7 doi: 10.1371/journal.pone.0035671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Simpson A.G., Gill E.E., Callahan H.A., Litaker R.W., Roger A.J. Early evolution within kinetoplastids (euglenozoa), and the late emergence of trypanosomatids. Protist. 2004;155:407–422. doi: 10.1078/1434461042650389. [DOI] [PubMed] [Google Scholar]
- 4.Vesteg M., Hadariova L., Horvath A., Estrano C.E., Schwartzbach S.D., Krajcovic J. Comparative molecular cell biology of phototrophic euglenids and parasitic trypanosomatids sheds light on the ancestor of Euglenozoa. Biol Rev Camb Philos Soc. 2019;94:1701–1721. doi: 10.1111/brv.12523. [DOI] [PubMed] [Google Scholar]
- 5.Banuls A.L., Hide M., Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1–109. doi: 10.1016/S0065-308X(06)64001-3. [DOI] [PubMed] [Google Scholar]
- 6.Burza S., Croft S.L., Boelaert M. Leishmaniasis. Lancet. 2018;392:951–970. doi: 10.1016/S0140-6736(18)31204-2. [DOI] [PubMed] [Google Scholar]
- 7.Silverman J.M., Reiner N.E. Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection. Front Cell Infect Microbiol. 2011;1:26. doi: 10.3389/fcimb.2011.00026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Singh O.P., Hasker E., Sacks D., Boelaert M., Sundar S. Asymptomatic leishmania infection: a new challenge for Leishmania control. Clin Infect Dis. 2014;58:1424–1429. doi: 10.1093/cid/ciu102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lee T.I., Young R.A. Transcription of eukaryotic protein-coding genes. Annu Rev Genet. 2000;34:77–137. doi: 10.1146/annurev.genet.34.1.77. [DOI] [PubMed] [Google Scholar]
- 10.Clayton C.E. Life without transcriptional control? From fly to man and back again. EMBO J. 2002;21:1881–1888. doi: 10.1093/emboj/21.8.1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309:436–442. doi: 10.1126/science.1112680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Peacock, C.S.; Seeger, K.; Harris, D.; Murphy, L.; Ruiz, J.C.; Quail, M.A.; Peters, N.; Adlem, E.; Tivey, A.; Aslett, M., et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007, 39, 839-847, doi:ng2053 [pii] 10.1038/ng2053. [DOI] [PMC free article] [PubMed]
- 13.Martinez-Calvillo, S.; Yan, S.; Nguyen, D.; Fox, M.; Stuart, K.; Myler, P.J. Transcription of Leishmania major Friedlin chromosome 1 initiates in both directions within a single region. Mol Cell 2003, 11, 1291-1299, doi:S1097276503001436 [pii].] [DOI] [PubMed]
- 14.Martinez-Calvillo S., Nguyen D., Stuart K., Myler P.J. Transcription initiation and termination on Leishmania major chromosome 3. Eukaryot Cell. 2004;3:506–517. doi: 10.1128/ec.3.2.506-517.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Choudhury K., Zander D., Kube M., Reinhardt R., Clos J. Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int J Parasitol. 2008;38:1411–1423. doi: 10.1016/j.ijpara.2008.03.005. [DOI] [PubMed] [Google Scholar]
- 16.Hombach A., Ommen G., Chrobak M., Clos J. The Hsp90-Sti1 interaction is critical forLeishmania donovani proliferation in both life cycle stages. Cell Microbiol. 2013;15:585–600. doi: 10.1111/cmi.12057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Liang X.H., Haritan A., Uliel S., Michaeli S. Trans and cis splicing in trypanosomatids: mechanism, factors, and regulation. Eukaryot Cell. 2003;2:830–840. doi: 10.1128/ec.2.5.830-840.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lynn M.A., McMaster W.R. Leishmania: conserved evolution–diverse diseases. Trends Parasitol. 2008;24:103–105. doi: 10.1016/j.pt.2007.11.006. [DOI] [PubMed] [Google Scholar]
- 19.Saar Y., Ransford A., Waldman E., Mazareb S., Amin-Spector S., Plumblee J. Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol Biochem Parasitol. 1998;95:9–20. doi: 10.1016/s0166-6851(98)00062-0. [DOI] [PubMed] [Google Scholar]
- 20.Barak E., Amin-Spector S., Gerliak E., Goyard S., Holland N., Zilberstein D. Differentiation of Leishmania donovani in host-free system: analysis of signal perception and response. Mol Biochem Parasitol. 2005;141:99–108. doi: 10.1016/j.molbiopara.2005.02.004. [DOI] [PubMed] [Google Scholar]
- 21.Kröber-Boncardo C., Grünebast J., Clos J. Heat shock proteins in leishmania parasites. In: Asea A., editor. Heat Shock Proteins. Springer:; Dordrecht: 2020. [DOI] [Google Scholar]
- 22.Brandau S., Dresel A., Clos J. High constitutive levels of heat-shock proteins in human-pathogenic parasites of the genus Leishmania. Biochem J. 1995;310(Pt 1):225–232. doi: 10.1042/bj3100225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Quijada L., Soto M., Alonso C., Requena J.M. Analysis of post-transcriptional regulation operating on transcription products of the tandemly linked Leishmania infantum hsp70 genes. J Biol Chem. 1997;272:4493–4499. doi: 10.1074/jbc.272.7.4493. [DOI] [PubMed] [Google Scholar]
- 24.Leifso K., Cohen-Freue G., Dogra N., Murray A., McMaster W.R. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol. 2007;152:35–46. doi: 10.1016/j.molbiopara.2006.11.009. [DOI] [PubMed] [Google Scholar]
- 25.Alcolea P.J., Alonso A., Gomez M.J., Moreno I., Dominguez M., Parro V. Transcriptomics throughout the life cycle of Leishmania infantum: high down-regulation rate in the amastigote stage. Int J Parasitol. 2010;40:1497–1516. doi: 10.1016/j.ijpara.2010.05.013. [DOI] [PubMed] [Google Scholar]
- 26.Lahav T., Sivam D., Volpin H., Ronen M., Tsigankov P., Green A. Multiple levels of gene regulation mediate differentiation of the intracellular pathogen Leishmania. FASEB J. 2011;25:515–525. doi: 10.1096/fj.10-157529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Rosenzweig, D.; Smith, D.; Opperdoes, F.; Stern, S.; Olafson, R.W.; Zilberstein, D. Retooling Leishmania metabolism: from sand fly gut to human macrophage. FASEB J 2008, 22, 590-602, doi:fj.07-9254com [pii] 10.1096/fj.07-9254com. [DOI] [PubMed]
- 28.Clayton C., Shapira M. Post-transcriptional regulation of gene expression in trypanosomes and leishmanias. Mol Biochem Parasitol. 2007;156:93–101. doi: 10.1016/j.molbiopara.2007.07.007. [DOI] [PubMed] [Google Scholar]
- 29.Charest H., Zhang W.W., Matlashewski G. The developmental expression of Leishmania donovani A2 amastigote-specific genes is post-transcriptionally mediated and involves elements located in the 3'-untranslated region. J Biol Chem. 1996;271:17081–17090. doi: 10.1074/jbc.271.29.17081. [DOI] [PubMed] [Google Scholar]
- 30.Yao C., Leidal K.G., Brittingham A., Tarr D.E., Donelson J.E., Wilson M.E. Biosynthesis of the major surface protease GP63 of Leishmania chagasi. Mol Biochem Parasitol. 2002;121:119–128. doi: 10.1016/s0166-6851(02)00030-0. [DOI] [PubMed] [Google Scholar]
- 31.Decuypere S., Vanaerschot M., Brunker K., Imamura H., Muller S., Khanal B. Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis. 2012;6 doi: 10.1371/journal.pntd.0001514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Azevedo A., Toledo J.S., Defina T., Pedrosa A.L., Cruz A.K. Leishmania major phosphoglycerate kinase transcript and protein stability contributes to differences in isoform expression levels. Exp Parasitol. 2015;159:222–226. doi: 10.1016/j.exppara.2015.09.008. [DOI] [PubMed] [Google Scholar]
- 33.Bifeld, E.; Lorenzen, S.; Bartsch, K.; Vasquez, J.J.; Siegel, T.N.; Clos, J. Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in Leishmania donovani. mSystems 2018, 3, doi:10.1128/mSystems.00214-18. [DOI] [PMC free article] [PubMed]
- 34.Mandal G., Mandal S., Sharma M., Charret K.S., Papadopoulou B., Bhattacharjee H. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. PLoS Negl Trop Dis. 2015;9 doi: 10.1371/journal.pntd.0003500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Bringaud F., Muller M., Cerqueira G.C., Smith M., Rochette A., El-Sayed N.M. Members of a large retroposon family are determinants of post-transcriptional gene expression in Leishmania. PLoS Pathog. 2007;3:1291–1307. doi: 10.1371/journal.ppat.0030136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Azizi H., Dumas C., Papadopoulou B. The Pumilio-domain protein PUF6 contributes to SIDER2 retroposon-mediated mRNA decay in Leishmania. RNA. 2017;23:1874–1885. doi: 10.1261/rna.062950.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Boucher N., Wu Y., Dumas C., Dube M., Sereno D., Breton M. A common mechanism of stage-regulated gene expression in Leishmania mediated by a conserved 3'-untranslated region element. J Biol Chem. 2002;277:19511–19520. doi: 10.1074/jbc.M200500200. [DOI] [PubMed] [Google Scholar]
- 38.Jensen B.C., Ramasamy G., Vasconcelos E.J., Ingolia N.T., Myler P.J., Parsons M. Extensive stage-regulation of translation revealed by ribosome profiling of Trypanosoma brucei. BMC Genomics. 2014;15:911. doi: 10.1186/1471-2164-15-911. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Vasquez J.J., Hon C.C., Vanselow J.T., Schlosser A., Siegel T.N. Comparative ribosome profiling reveals extensive translational complexity in different Trypanosoma brucei life cycle stages. Nucleic Acids Res. 2014;42:3623–3637. doi: 10.1093/nar/gkt1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Smircich P., Eastman G., Bispo S., Duhagon M.A., Guerra-Slompo E.P., Garat B. Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. BMC Genomics. 2015;16:443. doi: 10.1186/s12864-015-1563-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bente M., Harder S., Wiesgigl M., Heukeshoven J., Gelhaus C., Krause E. Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics. 2003;3:1811–1829. doi: 10.1002/pmic.200300462. [DOI] [PubMed] [Google Scholar]
- 42.Ingolia N.T., Ghaemmaghami S., Newman J.R., Weissman J.S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science. 2009;324:218–223. doi: 10.1126/science.1168978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kalesh K., Denny P.W. A BONCAT-iTRAQ method enables temporally resolved quantitative profiling of newly synthesised proteins in Leishmania mexicana parasites during starvation. PLoS Negl Trop Dis. 2019;13 doi: 10.1371/journal.pntd.0007651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Wiesgigl M., Clos J. Heat shock protein 90 homeostasis controls stage differentiation in Leishmania donovani. Mol Biol Cell. 2001;12:3307–3316. doi: 10.1091/mbc.12.11.3307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cloutier S., Laverdiere M., Chou M.N., Boilard N., Chow C., Papadopoulou B. Translational control through eIF2alpha phosphorylation during the Leishmania differentiation process. PLoS ONE. 2012;7 doi: 10.1371/journal.pone.0035085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Jara M., Maes I., Imamura H., Domagalska M.A., Dujardin J.C., Arevalo J. Tracking of quiescence in Leishmania by quantifying the expression of GFP in the ribosomal DNA locus. Sci Rep. 2019;9:18951. doi: 10.1038/s41598-019-55486-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Dhalia R., Reis C.R., Freire E.R., Rocha P.O., Katz R., Muniz J.R. Translation initiation in Leishmania major: characterisation of multiple eIF4F subunit homologues. Mol Biochem Parasitol. 2005;140:23–41. doi: 10.1016/j.molbiopara.2004.12.001. [DOI] [PubMed] [Google Scholar]
- 48.Zinoviev A., Leger M., Wagner G., Shapira M. A novel 4E-interacting protein in Leishmania is involved in stage-specific translation pathways. Nucleic Acids Res. 2011;39:8404–8415. doi: 10.1093/nar/gkr555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Morales M.A., Watanabe R., Laurent C., Lenormand P., Rousselle J.C., Namane A. Phosphoproteomic analysis ofLeishmania donovanipro- and amastigote stages. Proteomics. 2008;8:350–363. doi: 10.1002/pmic.200700697. [DOI] [PubMed] [Google Scholar]
- 50.Rosenzweig D., Smith D., Myler P.J., Olafson R.W., Zilberstein D. Post-translational modification of cellular proteins during Leishmania donovani differentiation. Proteomics. 2008;8:1843–1850. doi: 10.1002/pmic.200701043. [DOI] [PubMed] [Google Scholar]
- 51.Morales, M.; Watanabe, R.; Dacher, M.; Chafey, P.; Osorio y Fortéa, J.; Beverley, S.; Ommen, G.; Clos, J.; Hem, S.; Lenormand, P., et al. Phosphoproteome dynamics reveals heat shock protein complexes specific to theLeishmaniainfectious stage. Proc Natl Acad Sci U S A 2010, 107, 8381-8386. [DOI] [PMC free article] [PubMed]
- 52.Wiese M. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. Embo J. 1998;17:2619–2628. doi: 10.1093/emboj/17.9.2619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Wiese M., Kuhn D., Grunfelder C.G. Protein kinase involved in flagellar-length control. Eukaryot Cell. 2003;2:769–777. doi: 10.1128/EC.2.4.769-777.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Bengs F., Scholz A., Kuhn D., Wiese M. LmxMPK9, a mitogen-activated protein kinase homologue affects flagellar length in Leishmania mexicana. Mol Microbiol. 2005;55:1606–1615. doi: 10.1111/j.1365-2958.2005.04498.x. [DOI] [PubMed] [Google Scholar]
- 55.Kuhn D., Wiese M. LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation. Mol Microbiol. 2005;56:1169–1182. doi: 10.1111/j.1365-2958.2005.04614.x. [DOI] [PubMed] [Google Scholar]
- 56.Wang Q., Melzer I.M., Kruse M., Sander-Juelch C., Wiese M. LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes ofLeishmania mexicana. Kinetoplastid Biol Dis. 2005;4:6. doi: 10.1186/1475-9292-4-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Erdmann M., Scholz A., Melzer I.M., Schmetz C., Wiese M. Interacting protein kinases involved in the regulation of flagellar length. Mol Biol Cell. 2006;17:2035–2045. doi: 10.1091/mbc.E05-10-0976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.von Freyend, S.J.; Rosenqvist, H.; Fink, A.; Melzer, I.M.; Clos, J.; Jensen, O.N.; Wiese, M. LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5. Int J Parasitol 2010, 40, 969-978, doi:S0020-7519(10)00062-7 [pii] 10.1016/j.ijpara.2010.02.004. [DOI] [PubMed]
- 59.Cayla M., Rachidi N., Leclercq O., Schmidt-Arras D., Rosenqvist H., Wiese M. Transgenic analysis of the Leishmania MAP kinase MPK10 reveals an auto-inhibitory mechanism crucial for stage-regulated activity and parasite viability. PLoS Pathog. 2014;10 doi: 10.1371/journal.ppat.1004347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Kaur P., Garg M., Hombach-Barrigah A., Clos J., Goyal N. MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex. Sci Rep. 2017;7:10202. doi: 10.1038/s41598-017-09725-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Silverman, J.M.; Clos, J.; de'Oliveira, C.C.; Shirvani, O.; Fang, Y.; Wang, C.; Foster, L.J.; Reiner, N.E. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci 2010, 123, 842-852, doi:jcs.056465 [pii] 10.1242/jcs.056465. [DOI] [PubMed]
- 62.Rachidi N., Taly J.F., Durieu E., Leclercq O., Aulner N., Prina E. Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection. Antimicrob Agents Chemother. 2014;58:1501–1515. doi: 10.1128/AAC.02022-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Martel, D.; Beneke, T.; Gluenz, E.; Spath, G.F.; Rachidi, N. Characterisation of Casein Kinase 1.1 in Leishmania donovani Using the CRISPR Cas9 Toolkit. Biomed Res Int 2017, 2017, 4635605, doi:10.1155/2017/4635605. [DOI] [PMC free article] [PubMed]
- 64.Hombach-Barrigah A., Bartsch K., Smirlis D., Rosenqvist H., MacDonald A., Dingli F. Leishmania donovani 90 kD Heat Shock Protein - Impact of Phosphosites on Parasite Fitness, Infectivity and Casein Kinase Affinity. Sci Rep. 2019;9:5074. doi: 10.1038/s41598-019-41640-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Reinbothe S., Parthier B. Translational regulation of plastid gene expression in Euglena gracilis. FEBS Lett. 1990;265:7–11. doi: 10.1016/0014-5793(90)80870-o. [DOI] [PubMed] [Google Scholar]
- 66.Keller M., Chan R.L., Tessier L.H., Weil J.H., Imbault P. Post-transcriptional regulation by light of the biosynthesis of Euglena ribulose-1,5-bisphosphate carboxylase/oxygenase small subunit. Plant Mol Biol. 1991;17:73–82. doi: 10.1007/BF00036807. [DOI] [PubMed] [Google Scholar]
- 67.Myler P.J., Beverley S.M., Cruz A.K., Dobson D.E., Ivens A.C., McDonagh P.D. The Leishmania genome project: new insights into gene organization and function. Med Microbiol Immunol (Berl) 2001;190:9–12. doi: 10.1007/s004300100070. [DOI] [PubMed] [Google Scholar]
- 68.Lee, M.G.; Atkinson, B.L.; Giannini, S.H.; Van der Ploeg, L.H. Structure and expression of the hsp 70 gene family of Leishmania major [published erratum appears in Nucleic Acids Res 1988 Dec 9;16(23):11400- 1]. Nucleic Acids Res 1988, 16, 9567-9585. [DOI] [PMC free article] [PubMed]
- 69.Bock J.H., Langer P.J. Sequence and genomic organization of the hsp70 genes of Leishmania amazonensis. Mol Biochem Parasitol. 1993;62:187–197. doi: 10.1016/0166-6851(93)90108-a. [DOI] [PubMed] [Google Scholar]
- 70.Hübel A., Clos J. The genomic organization of the HSP83 gene locus is conserved in three Leishmania species. Exp Parasitol. 1996;82:225–228. doi: 10.1006/expr.1996.0029. [DOI] [PubMed] [Google Scholar]
- 71.Shapira M., Zilka A., Garlapati S., Dahan E., Dahan I., Yavesky V. Post transcriptional control of gene expression in Leishmania. Med Microbiol Immunol (Berl) 2001;190:23–26. doi: 10.1007/s004300100073. [DOI] [PubMed] [Google Scholar]
- 72.Folgueira C., Requena J.M. A postgenomic view of the heat shock proteins in kinetoplastids. FEMS Microbiol Rev. 2007;31:359–377. doi: 10.1111/j.1574-6976.2007.00069.x. [DOI] [PubMed] [Google Scholar]
- 73.Cruz A., Coburn C.M., Beverley S.M. Double targeted gene replacement for creating null mutants. Proc Natl Acad Sci USA. 1991;88:7170–7174. doi: 10.1073/pnas.88.16.7170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Cruz A.K., Titus R., Beverley S.M. Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc Natl Acad Sci USA. 1993;90:1599–1603. doi: 10.1073/pnas.90.4.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Krobitsch S., Clos J. Cross-species homologous recombination in Leishmania donovani reveals the sites of integration. Mol Biochem Parasitol. 2000;107:123–128. doi: 10.1016/s0166-6851(00)00180-8. [DOI] [PubMed] [Google Scholar]
- 76.Imamura H., Dujardin J.C. A guide to next generation sequence analysis of leishmania genomes. Methods Mol Biol. 2019;1971:69–94. doi: 10.1007/978-1-4939-9210-2_3. [DOI] [PubMed] [Google Scholar]
- 77.Mannaert A., Downing T., Imamura H., Dujardin J.C. Adaptive mechanisms in pathogens: universal aneuploidy inLeishmania. Trends in parasitology. 2012;28:370–376. doi: 10.1016/j.pt.2012.06.003. [DOI] [PubMed] [Google Scholar]
- 78.Lachaud L., Bourgeois N., Kuk N., Morelle C., Crobu L., Merlin G. Constitutive mosaic aneuploidy is a unique genetic feature widespread in the Leishmania genus. Microbes Infect. 2014;16:61–66. doi: 10.1016/j.micinf.2013.09.005. [DOI] [PubMed] [Google Scholar]
- 79.Sterkers Y., Crobu L., Lachaud L., Pages M., Bastien P. Parasexuality and mosaic aneuploidy in Leishmania: alternative genetics. Trends Parasitol. 2014;30:429–435. doi: 10.1016/j.pt.2014.07.002. [DOI] [PubMed] [Google Scholar]
- 80.Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849–854. doi: 10.1046/j.1365-3156.2001.00778.x. [DOI] [PubMed] [Google Scholar]
- 81.Dube A., Singh N., Sundar S. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res. 2005 doi: 10.1007/s00436-005-1339-1. [DOI] [PubMed] [Google Scholar]
- 82.Croft S.L., Sundar S., Fairlamb A.H. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19:111–126. doi: 10.1128/CMR.19.1.111-126.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Ostyn B., Hasker E., Dorlo T.P., Rijal S., Sundar S., Dujardin J.C. Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia. PLoS ONE. 2014;9 doi: 10.1371/journal.pone.0100220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Leprohon P., Legare D., Raymond F., Madore E., Hardiman G., Corbeil J. Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistantLeishmania infantum. Nucleic Acids Res. 2009;37:1387–1399. doi: 10.1093/nar/gkn1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Laffitte M.N., Leprohon P., Papadopoulou B., Ouellette M. Plasticity of the Leishmania genome leading to gene copy number variations and drug resistance. F1000Res. 2016;5:2350. doi: 10.12688/f1000research.9218.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Dumetz, F.; Imamura, H.; Sanders, M.; Seblova, V.; Myskova, J.; Pescher, P.; Vanaerschot, M.; Meehan, C.J.; Cuypers, B.; De Muylder, G., et al. Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression. MBio 2017, 8, doi:10.1128/mBio.00599-17. [DOI] [PMC free article] [PubMed]
- 87.Dumetz, F.; Cuypers, B.; Imamura, H.; Zander, D.; D'Haenens, E.; Maes, I.; Domagalska, M.A.; Clos, J.; Dujardin, J.C.; De Muylder, G. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent. mSphere 2018, 3, doi:10.1128/mSphere.00548-17. [DOI] [PMC free article] [PubMed]
- 88.Sterkers Y., Lachaud L., Crobu L., Bastien P., Pages M. FISH analysis reveals aneuploidy and continual generation of chromosomal mosaicism in Leishmania major. Cell Microbiol. 2011;13:274–283. doi: 10.1111/j.1462-5822.2010.01534.x. [DOI] [PubMed] [Google Scholar]
- 89.Sterkers Y., Lachaud L., Bourgeois N., Crobu L., Bastien P., Pages M. Novel insights into genome plasticity in Eukaryotes: mosaic aneuploidy in Leishmania. Mol Microbiol. 2012;86:15–23. doi: 10.1111/j.1365-2958.2012.08185.x. [DOI] [PubMed] [Google Scholar]
- 90.Domagalska M.A., Imamura H., Sanders M., Van den Broeck F., Bhattarai N.R., Vanaerschot M. Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis. 2019;13 doi: 10.1371/journal.pntd.0007900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Pellman D. Cell biology: aneuploidy and cancer. Nature. 2007;446:38–39. doi: 10.1038/446038a. [DOI] [PubMed] [Google Scholar]
- 92.Torres E.M., Williams B.R., Amon A. Aneuploidy: cells losing their balance. Genetics. 2008;179:737–746. doi: 10.1534/genetics.108.090878. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Rutledge S.D., Cimini D. Consequences of aneuploidy in sickness and in health. Curr Opin Cell Biol. 2016;40:41–46. doi: 10.1016/j.ceb.2016.02.003. [DOI] [PubMed] [Google Scholar]
- 94.Kröber-Boncardo C., Lorenzen S., Brinker C., Clos J. Casein kinase 1.2 over expression restores stress resistance to Leishmania donovani HSP23 null mutants. Sci Rep. 2020;10:15969. doi: 10.1038/s41598-020-72724-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Brochu C., Haimeur A., Ouellette M. The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania. Cell Stress Chaperones. 2004;9:294–303. doi: 10.1379/CSC-15R1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Vergnes B., Gourbal B., Girard I., Sundar S., Drummelsmith J., Ouellette M. A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics. 2007;6:88–101. doi: 10.1074/mcp.M600319-MCP200. [DOI] [PubMed] [Google Scholar]
- 97.Vacchina P., Norris-Mullins B., Carlson E.S., Morales M.A. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani. Parasites Vectors. 2016;9:621. doi: 10.1186/s13071-016-1904-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellette M. Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J. 1997;16:3057–3065. doi: 10.1093/emboj/16.11.3057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Ubeda J.M., Raymond F., Mukherjee A., Plourde M., Gingras H., Roy G. Genome-wide stochastic adaptive DNA amplification at direct and inverted DNA repeats in the parasiteLeishmania. PLoS Biol. 2014;12 doi: 10.1371/journal.pbio.1001868. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Iantorno, S.A.; Durrant, C.; Khan, A.; Sanders, M.J.; Beverley, S.M.; Warren, W.C.; Berriman, M.; Sacks, D.L.; Cotton, J.A.; Grigg, M.E. Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage. mBio 2017, 8, doi:10.1128/mBio.01393-17. [DOI] [PMC free article] [PubMed]
- 101.Bartsch K., Hombach-Barrigah A., Clos J. Hsp90 inhibitors radicicol and geldanamycin have opposing effects on Leishmania Aha1-dependent proliferation. Cell Stress Chaperones. 2017;22:729–742. doi: 10.1007/s12192-017-0800-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Perez-Victoria F.J., Gamarro F., Ouellette M., Castanys S. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J Biol Chem. 2003;278:49965–49971. doi: 10.1074/jbc.M308352200. [DOI] [PubMed] [Google Scholar]
- 103.Laffitte M.C., Leprohon P., Legare D., Ouellette M. Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance. Parasitol Res. 2016;115:3699–3703. doi: 10.1007/s00436-016-5195-y. [DOI] [PubMed] [Google Scholar]
- 104.Bifeld E., Chrobak M., Zander D., Schleicher U., Schonian G., Clos J. Geographical sequence variation in the Leishmania major virulence factor P46. Infect Genet Evol. 2015;30:195–205. doi: 10.1016/j.meegid.2014.12.029. [DOI] [PubMed] [Google Scholar]
- 105.Beverley S.M., Turco S.J. Identification of genes mediating lipophosphoglycan biosynthesis by functional complementation of Leishmania donovani mutants. Ann Trop Med Parasitol. 1995;89(Suppl 1):11–17. doi: 10.1080/00034983.1995.11813009. [DOI] [PubMed] [Google Scholar]
- 106.Cotrim P.C., Garrity L.K., Beverley S.M. Isolation of genes mediating resistance to inhibitors of nucleoside and ergosterol metabolism in Leishmania by overexpression/selection. J Biol Chem. 1999;274:37723–37730. doi: 10.1074/jbc.274.53.37723. [DOI] [PubMed] [Google Scholar]
- 107.Hoyer C., Mellenthin K., Schilhabel M., Platzer M., Clos J. Leishmaniaand the Leishmaniases: Use of genetic complementation to identify gene(s) which specify species-specific organ tropism ofLeishmania. Med Microbiol Immunol. 2001;190:53–56. doi: 10.1007/s004300100077. [DOI] [PubMed] [Google Scholar]
- 108.Clos J., Choudhury K. Functional cloning as a means to identifyLeishmaniagenes involved in drug resistance. Mini Rev Med Chem. 2006;6:123–129. doi: 10.2174/138955706775476028. [DOI] [PubMed] [Google Scholar]
- 109.Nuhs, A.; Schafer, C.; Zander, D.; Trube, L.; Tejera Nevado, P.; Schmidt, S.; Arevalo, J.; Adaui, V.; Maes, L.; Dujardin, J.C., et al. A novel marker, ARM58, confers antimony resistance to Leishmania spp. International journal for parasitology. Drugs and drug resistance 2014, 4, 37-47, doi:10.1016/j.ijpddr.2013.11.004. [DOI] [PMC free article] [PubMed]
- 110.LeBowitz J.H., Smith H.Q., Rusche L., Beverley S.M. Coupling of poly(A) site selection and trans-splicing in Leishmania. Genes Dev. 1993;7:996–1007. doi: 10.1101/gad.7.6.996. [DOI] [PubMed] [Google Scholar]
- 111.Gazanion E., Fernandez-Prada C., Papadopoulou B., Leprohon P., Ouellette M. Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania. Proc Natl Acad Sci U S A. 2016;113:E3012–3021. doi: 10.1073/pnas.1520693113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Fernandez-Prada, C.; Sharma, M.; Plourde, M.; Bresson, E.; Roy, G.; Leprohon, P.; Ouellette, M. High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms. International journal for parasitology. Drugs and drug resistance 2018, 8, 165-173, doi:10.1016/j.ijpddr.2018.03.004. [DOI] [PMC free article] [PubMed]
- 113.Potvin J.E., Leprohon P., Gazanion E., Sharma M., Fernandez-Prada C., Ouellette M. Cos-Seq: a high-throughput gain-of-function screen for drug resistance studies in leishmania. Methods Mol Biol. 2019;1971:141–167. doi: 10.1007/978-1-4939-9210-2_7. [DOI] [PubMed] [Google Scholar]
- 114.Borsari, C.; Jimenez-Anton, M.D.; Eick, J.; Bifeld, E.; Torrado, J.J.; Olias-Molero, A.I.; Corral, M.J.; Santarem, N.; Baptista, C.; Severi, L., et al. Discovery of a benzothiophene-flavonol halting miltefosine and antimonial drug resistance in Leishmania parasites through the application of medicinal chemistry, screening and genomics. Eur J Med Chem 2019, 183, 111676, doi:10.1016/j.ejmech.2019.111676. [DOI] [PubMed]


